Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burt Nabors

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
Cancer|May 29, 2023
Racial and socioeconomic disparities in glioblastoma outcomes: A single-center, retrospective cohort studyDagoberto Estevez-Ordonez, Moaaz Abdelrashid, Elizabeth Coffee, et al.
Journal of Neuro-Oncology|January 15, 2018
Handedness and the risk of gliomaBriana Miller, Noah C Peeri, Louis Burt Nabors, et al.
Journal of Neuro-Oncology|August 20, 2015
Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomasJaishri O Blakeley, Stuart A Grossman, Tom Mikkelsen, et al.
International Journal of Oncology|May 14, 2014
The role of Src family kinases in growth and migration of glioma stem cellsXiaosi Han, Wenbin Zhang, Xiuhua Yang, et al.
Journal of Neurosurgery|April 26, 2024
Longitudinal brain volumetrics in glioma survivorsAndrew M McDonald, Donna L Murdaugh, Katherine A Heinzman, et al.
Journal of Neuro-Oncology|October 21, 2023
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastomaRoy Strowd, Benjamin Ellingson, Catalina Raymond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Phase I and correlative biology study of cilengitide in patients with recurrent malignant gliomaL Burt Nabors, Tom Mikkelsen, Steven S Rosenfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS TumorsMrinal M Gounder, Lakshmi Nayak, Solmaz Sahebjam, et al.
Neuro-Oncology|March 6, 2024
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse gliomaIsabel Arrillaga-Romany, Andrew Lassman, Susan L McGovern, et al.
Cancer Causes & Control : CCC|March 6, 2017
Older age at the completion of linear growth is associated with an increased risk of adult gliomaRebecca B Little, L Burt Nabors, Jeffrey J Olson, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
Cancer|May 29, 2023
Racial and socioeconomic disparities in glioblastoma outcomes: A single-center, retrospective cohort studyDagoberto Estevez-Ordonez, Moaaz Abdelrashid, Elizabeth Coffee, et al.
Journal of Neuro-Oncology|January 15, 2018
Handedness and the risk of gliomaBriana Miller, Noah C Peeri, Louis Burt Nabors, et al.
Journal of Neuro-Oncology|August 20, 2015
Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomasJaishri O Blakeley, Stuart A Grossman, Tom Mikkelsen, et al.
International Journal of Oncology|May 14, 2014
The role of Src family kinases in growth and migration of glioma stem cellsXiaosi Han, Wenbin Zhang, Xiuhua Yang, et al.
Journal of Neurosurgery|April 26, 2024
Longitudinal brain volumetrics in glioma survivorsAndrew M McDonald, Donna L Murdaugh, Katherine A Heinzman, et al.
Journal of Neuro-Oncology|October 21, 2023
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastomaRoy Strowd, Benjamin Ellingson, Catalina Raymond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Phase I and correlative biology study of cilengitide in patients with recurrent malignant gliomaL Burt Nabors, Tom Mikkelsen, Steven S Rosenfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS TumorsMrinal M Gounder, Lakshmi Nayak, Solmaz Sahebjam, et al.
Neuro-Oncology|March 6, 2024
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse gliomaIsabel Arrillaga-Romany, Andrew Lassman, Susan L McGovern, et al.
Cancer Causes & Control : CCC|March 6, 2017
Older age at the completion of linear growth is associated with an increased risk of adult gliomaRebecca B Little, L Burt Nabors, Jeffrey J Olson, et al.
Pageof 14